Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 461 of 1,261
  1. US 10471051

    Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer

    Asana BioSciences, LLC · Granted Nov 12, 2019 · Expires Nov 7, 2039

    granted
  2. US 10472425

    Stabilized formulations containing anti-PCSK9 antibodies

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 12, 2019 · Expires Nov 7, 2039

    granted
  3. US 10472385

    Triterpene-glycosides as sweeteners or sweetener enhancers

    Analyticon Discovery GmbH · Granted Nov 12, 2019 · Expires Nov 7, 2039

    granted
  4. US 10472629

    Methods and compositions for modlating apolipoprotein (A) expression

    Ionis Pharmaceuticals, Inc. · Granted Nov 12, 2019 · Expires Nov 7, 2039

    granted
  5. US 10472628

    Lipid formulated compositions and methods for inhibiting expression of Serum Amyloid A gene

    Alnylam Pharmaceuticals, Inc. · Granted Nov 12, 2019 · Expires Nov 7, 2039

    granted
  6. US 10472412

    Bispecific multivalent fusion proteins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 12, 2019 · Expires Nov 7, 2039

    granted
  7. US 10472394

    Cyclosporine analogue mixtures and their use as immunomodulating agents

    AURINIA PHARMACEUTICALS INC. · Granted Nov 12, 2019 · Expires Nov 7, 2039

    granted
  8. US 10472386

    Bile acid derivatives as FXR agonists and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Nov 12, 2019 · Expires Nov 7, 2039

    granted
  9. US 10472381

    Sialic acid derivatives

    Reinhard Brossmer · Granted Nov 12, 2019 · Expires Nov 7, 2039

    granted
  10. US 10472366

    Glucuronide prodrugs of tofacitinib

    Theravance Biopharma R&D IP, LLC · Granted Nov 12, 2019 · Expires Nov 7, 2039

    granted
  11. US 10472376

    Amide compound

    Takeda Pharmaceutical Company Limited · Granted Nov 12, 2019 · Expires Nov 7, 2039

    granted
  12. US 10472346

    Potent gamma-secretase modulators

    The Regents of the University of California · Granted Nov 12, 2019 · Expires Nov 7, 2039

    granted
  13. US 10472340

    Substituted phenothiazines as mitochondrial agents

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Nov 12, 2019 · Expires Nov 7, 2039

    granted
  14. US 10472335

    Crystalline(2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-bipheny]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof

    Theravance Biopharma R&D IP, LLC · Granted Nov 12, 2019 · Expires Nov 7, 2039

    granted
  15. US 10471148

    Progesterone formulations having a desirable PK profile

    Compass Therapeutics LLC · Granted Nov 12, 2019 · Expires Nov 7, 2039

    granted
  16. US 10472330

    Substituted triazenes protected from degradation by carboxylation of N1

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Nov 12, 2019 · Expires Nov 7, 2039

    granted
  17. US 10471134

    Enzymes and methods for cleaving N-glycans from glycoproteins

    The Regents of the University of California · Granted Nov 12, 2019 · Expires Nov 7, 2039

    granted
  18. US 10471076

    Compositions and methods to treat vision disorders

    The Regents of the University of California · Granted Nov 12, 2019 · Expires Nov 7, 2039

    granted
  19. US 10471069

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Nov 12, 2019 · Expires Nov 7, 2039

    granted
  20. US 10471109

    Compositions and methods for promoting nitric oxide production through an oral delivery system

    The Board of Regents of the University of Texas System · Granted Nov 12, 2019 · Expires Nov 7, 2039

    granted
  21. US 10471072

    Vaginal inserted estradiol pharmaceutical compositions and methods

    Compass Therapeutics LLC · Granted Nov 12, 2019 · Expires Nov 7, 2039

    granted
  22. US 10471123

    Methods and compositions for treating Huntington's disease

    Sangamo Therapeutics, Inc. · Granted Nov 12, 2019 · Expires Nov 7, 2039

    granted
  23. US 10471055

    Methods of treating cancer patients with farnesyltransferase inhibitors

    Kura Oncology, Inc. · Granted Nov 12, 2019 · Expires Nov 7, 2039

    granted
  24. US 10471068

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Nov 12, 2019 · Expires Nov 7, 2039

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.